This presentation discusses the prevalence and characteristics of non-hormonal cancer, focusing on triple negative breast cancer (TNBC). It explores the physiology and pathophysiology of TNBC, including the absence of hormonal effects and the presence of lumps or thickening in the breast. The drug of choice for TNBC, Adriamycin, is also discussed. The presentation highlights the relevance of oncology in nursing practice and emphasizes the need for improved treatment methods to enhance the health of women with TNBC.